Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Marja-Riitta Taskinen Helen M. Colhoun John J. P. Kastelein Jennifer G Robinson |
| Publication date | July 2, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |